Specialties & Services

Neuro-Oncology

Saint Luke’s Neuro-Oncology is a comprehensive brain and spine tumor program that uses advanced treatments, surgical techniques, and sophisticated imaging to treat the most challenging tumors. Patients will meet with experts in oncology and surgery, making it convenient—and fast—to move from diagnosis to treatment.

Our experts are highly experienced in treating brain and spine tumors at every phase, including initial diagnosis, second opinion, and recurrence. Our multidisciplinary team meets each week to create a treatment plan tailored to patients' specific needs. Specialties include:  

Brain and spine tumor treatment

Our neuro-oncology team has all the tools to treat complex brain tumors:

  • Advanced surgical technologies to help protect a patient’s vision, movement, and other important functions.
  • Radiation techniques that target tumors and areas where cancer may recur. We offer radiation guided by sophisticated imaging not available at most hospitals and targeted radiation using GammaTile®.
  • Carefully tailored chemotherapy treatments designed to be effective while minimizing side effects.
  • Access to clinical trials investigating new and improved treatments for brain and spine tumors—sometimes offering therapies years before they are available elsewhere.

Conditions we treat include

Patient-centered care

Our team of physicians and advanced practice providers are patient centered and firmly believe in fully educating patients through every step of the treatment process. New patients will receive a call back within 24 business hours and be scheduled as quickly as needed. A dedicated neuro-oncology nurse navigator assists patients throughout the care journey. Our goal is to give our patients the best quality of life as we treat their disease.

Saint Luke's accepts most major insurance plans. View accepted insurance list.

Call 816-932-5795 to schedule an appointment.

Available clinical trials

Our team offers groundbreaking clinical trials not available at other hospitals in the region. These trials offer hope for glioblastoma and other aggressive tumors that frequently recur despite standard therapies. 

Now enrolling for these clinical trials

Newly diagnosed glioblastoma

  • Phase II Double-blind, Randomized, Prospective, Placebo Controlled Study of NanO2TM Combined With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme (RESTORE)
  • A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly Diagnosed, MGMT Unmethylated Glioblastoma

Recurrent glioblastoma

  • Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma (MOAB)

     

  • Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of the Oncolytic HSV1 MVR-C5252 (PuMP)

Supportive care

  • Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy-Induced Neuropathic Pain

Call 816-932-5795 to learn more about clinical trials.

Locations
Saint Luke's Neuroscience Institute building photo

Saint Luke's Neuro-Oncology

4320 Wornall Road Suite 710
Kansas City, MO 64111
816-932-5795 More about Saint Luke's Neuro-Oncology